Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
Mohamed Salla(Lebanese International University), Shairaz Baksh(University of Alberta), Marilyn Gordon(University of Calgary), Justine Lai, Levinus A. Dieleman(University of North Carolina at Chapel Hill), Samantha Capicio(University of Alberta), Aducio Thiesen(University of Alberta), Jimmy A. Guo(Broad Institute), Eytan Wine(University of Alberta), Harshad Joshi(P. D. Hinduja Hospital and Medical Research Centre), Jason R.B. Dyck(University of Alberta), Heather Armstrong(University of Alberta), H Dooky(University of Alberta), Rosica Valcheva(University of Alberta)
Cited by 20
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
|Nature Genetics|2022|415
Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension
|Circulation|2010|409
Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte
|Journal of Biological Chemistry|2004|330
A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels
|Journal of Biological Chemistry|2002|260